Arginine in Treating Patients With Anti-VEGF Induced Kidney Injury

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This phase II trial studies how well arginine works in treating patients with kidney injury caused by anti-VEGF drugs used in standard treatment for cancer. Arginine is a nutritional supplement that may control side effects of anti-cancer drugs such as high blood pressure and protein in the urine and may also help to improve kidney function in patients.
Epistemonikos ID: c3b6299b08068a8f6cce6100caece2a37b2ee7cd
First added on: Jun 14, 2024